Welcome to Crene Biotechnology!

+86-576-88205808

Product :

RDC-3317 Aripiprazole lauroxil

RDC-3317 Aripiprazole lauroxil 1259305-29-7
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:RDC-3317 Aripiprazole lauroxil Purity:98% min
CAS NO:1259305-29-7 Solubility:
Molecular Formula:C36H51Cl2N3O4 Package:Package according to customer requirements
Molecular Weight:660.714 Storage:Store at -20℃
Quality control
Remarks
Aripiprazole lauroxil, aslo known as RDC 3317, is a long-acting injectable atypical antipsychotic. It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia. 
References

1: Aggarwal A, Gopalakrishna G, Lauriello J. Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. Clin Schizophr Relat Psychoses. 2016 Spring;10(1):58-63. doi: 10.3371/csrp.AGGA.040316. PubMed PMID: 27074333.

2: Fellner C. Pharmaceutical Approval Update. P T. 2015 Dec;40(12):807-8. PubMed PMID: 26681901; PubMed Central PMCID: PMC4671464.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China